184 related articles for article (PubMed ID: 32117764)
1. From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision Medicine.
Rao SR; Somarelli JA; Altunel E; Selmic LE; Byrum M; Sheth MU; Cheng S; Ware KE; Kim SY; Prinz JA; Devos N; Corcoran DL; Moseley A; Soderblom E; Hsu SD; Eward WC
Front Oncol; 2020; 10():117. PubMed ID: 32117764
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
[TBL] [Abstract][Full Text] [Related]
3. Canine sarcomas as a surrogate for the human disease.
Gustafson DL; Duval DL; Regan DP; Thamm DH
Pharmacol Ther; 2018 Aug; 188():80-96. PubMed ID: 29378221
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships.
Klosowski M; Haines L; Alfino L; McMellen A; Leibowitz M; Regan D
Front Oncol; 2023; 13():1130215. PubMed ID: 37035209
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma.
Somarelli JA; Rupprecht G; Altunel E; Flamant EM; Rao S; Sivaraj D; Lazarides AL; Hoskinson SM; Sheth MU; Cheng S; Kim SY; Ware KE; Agarwal A; Cullen MM; Selmic LE; Everitt JI; McCall SJ; Eward C; Eward WC; Hsu DS
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187254
[TBL] [Abstract][Full Text] [Related]
6. Precision Oncology in Sarcomas: Divide and Conquer.
Carmagnani Pestana R; Groisberg R; Roszik J; Subbiah V
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914012
[TBL] [Abstract][Full Text] [Related]
7. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
8. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
9. Alternative lengthening of telomeres does exist in various canine sarcomas.
Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
[TBL] [Abstract][Full Text] [Related]
10. Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
Berlow NE; Rikhi R; Geltzeiler M; Abraham J; Svalina MN; Davis LE; Wise E; Mancini M; Noujaim J; Mansoor A; Quist MJ; Matlock KL; Goros MW; Hernandez BS; Doung YC; Thway K; Tsukahara T; Nishio J; Huang ET; Airhart S; Bult CJ; Gandour-Edwards R; Maki RG; Jones RL; Michalek JE; Milovancev M; Ghosh S; Pal R; Keller C
BMC Cancer; 2019 Jun; 19(1):593. PubMed ID: 31208434
[TBL] [Abstract][Full Text] [Related]
11. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
[TBL] [Abstract][Full Text] [Related]
12. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
[TBL] [Abstract][Full Text] [Related]
13. Canine models of human cancer: Bridging the gap to improve precision medicine.
Nance RL; Sajib AM; Smith BF
Prog Mol Biol Transl Sci; 2022; 189(1):67-99. PubMed ID: 35595353
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.
Canter RJ; Grossenbacher SK; Foltz JA; Sturgill IR; Park JS; Luna JI; Kent MS; Culp WTN; Chen M; Modiano JF; Monjazeb AM; Lee DA; Murphy WJ
J Immunother Cancer; 2017 Dec; 5(1):98. PubMed ID: 29254507
[TBL] [Abstract][Full Text] [Related]
15. Canine and human sarcomas exhibit predominant FGFR1 expression and impaired viability after inhibition of signaling.
Schweiger N; Hauck M; Steinhoff H; Sampl S; Reifinger M; Walter I; Kreilmeier T; Marian B; Grusch M; Berger W; Holzmann K; Kleiter M
Mol Carcinog; 2015 Sep; 54(9):841-52. PubMed ID: 24719266
[TBL] [Abstract][Full Text] [Related]
16. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
17. Classification of canine nonangiogenic, nonlymphogenic, gastrointestinal sarcomas based on microscopic, immunohistochemical, and molecular characteristics.
Hayes S; Yuzbasiyan-Gurkan V; Gregory-Bryson E; Kiupel M
Vet Pathol; 2013 Sep; 50(5):779-88. PubMed ID: 23456969
[TBL] [Abstract][Full Text] [Related]
18. Patient-Derived Organoids as a Promising Tool for Multimodal Management of Sarcomas.
Xu S; Tan S; Guo L
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686615
[TBL] [Abstract][Full Text] [Related]
19. Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
Colella G; Fazioli F; Gallo M; De Chiara A; Apice G; Ruosi C; Cimmino A; de Nigris F
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29466296
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.
Pfefferle AD; Agrawal YN; Koboldt DC; Kanchi KL; Herschkowitz JI; Mardis ER; Rosen JM; Perou CM
Dis Model Mech; 2016 Jul; 9(7):749-57. PubMed ID: 27149990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
